抑制 c-Myc 的 Hyper-O-GlcNAcylation 通过减轻角质形成细胞功能障碍加速糖尿病伤口愈合

2022-03-04 MedSci原创 MedSci原创

这些发现使 c-Myc 和 O-GlcNAc 成为糖尿病伤口的潜在治疗靶点。

以延迟愈合为特征的糖尿病足溃疡是糖尿病的主要并发症之一。已发现表皮角质形成细胞功能障碍在糖尿病伤口愈合能力差中起关键作用。在本研究中,williamhill asia 旨在探讨 c-Myc 及其 O-连接的 N-乙酰氨基葡萄糖 (O-GlcNAc) 糖基化 (O-GlcNAcylation) 修饰与糖尿病伤口中角质形成细胞功能障碍之间的关系。

图1 文章来源

研究团队采集了临床创面标本,并建立糖尿病大鼠全层皮肤缺损创面模型。采用H&E染色观察创面再上皮化,免疫组化检测增殖细胞核抗原、转谷氨酰胺酶1、loricrin、c-Myc和O-GlcNAc的表达。

观察过表达或敲低c-Myc后人永生化表皮细胞(HaCaT)细胞增殖、迁移和分化的功能变化。使用免疫沉淀和邻近连接测定证实了 c-Myc 的 O-GlcNAcylation。使用放线菌酮测量c-Myc蛋白的稳定性。

在糖尿病伤口上局部应用抑制 c-Myc 或 O-GlcNAc 的化合物后,观察到伤口愈合。

结果显示,糖尿病伤口边缘的角质形成细胞具有增殖分裂活跃、迁移缓慢、分化差的特点。

图2糖尿病患者伤口边缘的表皮角质形成细胞以增殖活跃、迁移缓慢和分化功能障碍为特征。

在糖尿病大鼠伤口边缘的 30 mM 葡萄糖和角质形成细胞中培养的 HaCaT 细胞中也观察到了类似的现象。

图3HaCaT 细胞在 30 mM 葡萄糖和大鼠糖尿病伤口边缘的角质形成细胞中培养,表现出活跃的增殖、缓慢的迁移和分化功能障碍。

c-Myc 在糖尿病大鼠、患者伤口边缘的角质形成细胞和用 30 mM 葡萄糖培养的 HaCaT 细胞中的表达增加。

c-Myc 表达增加促进增殖,同时抑制 HaCaT 细胞的迁移和分化,抑制 c-Myc 促进糖尿病伤口愈合。

图4c-Myc 促进增殖并抑制 HaCaT 细胞的迁移和分化。

用 30 mM 葡萄糖增加 c-Myc 的 O-GlcNAcylation 稳定了 c-Myc 蛋白。

抑制 O-GlcNAc 可改善角质形成细胞功能障碍并促进糖尿病伤口愈合。

图5c-Myc 的抑制促进了糖尿病伤口的愈合。

总而言之,这项研究首先评估了c-Myc O-GlcNAcylation的调节可能影响糖尿病伤口的愈合。c-Myc 表达增加促进异常增殖并抑制糖尿病伤口边缘角质形成细胞的迁移或分化。在高葡萄糖糖尿病状态下增加的 c-Myc 的 O-GlcNAcylation 稳定了 c-Myc 蛋白。抑制 c-Myc 或 O-GlcNAc 可缓解糖尿病伤口愈合延迟。

这些发现使 c-Myc 和 O-GlcNAc 成为糖尿病伤口的潜在治疗靶点。

原始文章:

Jie Zhang, Peilang Yang, Dan Liu, Min Gao, Jizhuang Wang, Tianyi Yu, Xiong Zhang, Yan Liu, Inhibiting Hyper-O-GlcNAcylation of c-Myc accelerate diabetic wound healing by alleviating keratinocyte dysfunction,Burns & Trauma, Volume 9, 2021, tkab031

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-09-18 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-03-02 guihongzh
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-03-02 lixiaol
  6. [GetPortalCommentsPageByObjectIdResponse(id=1729395, encodeId=c19f1e2939538, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 18 04:29:10 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274859, encodeId=e63d12e48596c, content=<a href='/topic/show?id=1bbc12404ba' target=_blank style='color:#2F92EE;'>#MYC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12404, encryptionId=1bbc12404ba, topicName=MYC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309923, encodeId=590013099230a, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421432, encodeId=bd6714214326e, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530308, encodeId=bfc5153030816, content=<a href='/topic/show?id=2c9738e9d2' target=_blank style='color:#2F92EE;'>#c-myc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3879, encryptionId=2c9738e9d2, topicName=c-myc)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b12082233, createdName=lixiaol, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586866, encodeId=0c6e1586866ea, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec517387980, createdName=般若傻瓜, createdTime=Wed Mar 02 12:29:10 CST 2022, time=2022-03-02, status=1, ipAttribution=)]

相关威廉亚洲官网

J Am Podiatr Med Assoc:富血小板血浆治疗糖尿病足溃疡的疗效如何?

糖尿病足溃疡(DFU)可以通过控制感染、血糖正常状态和溃疡清创来得到很好的控制,然后进行适当的包扎和足部减压。研究表明,大约90%的DFU经过适当的减压休息后在近6周内痊愈。富血小板血浆(PRP)可作

Diabetes Metab Res Rev:TIR与糖尿病足溃疡住院患者的截肢和全因死亡率呈负相关

糖尿病足溃疡(DFU)是糖尿病最严重的并发症之一。常伴有较高的发病率、截肢和死亡率。糖尿病患者中DFU的终生发生率为19%~34%。

糖尿病足福音?这项手术或可提供可观经济效益!

糖尿病神经病变、足部溃疡和下肢截肢的成本已经是巨大的,据报道,除糖尿病本身的成本外,公共和私人支付人的负担从90亿美元到130亿美元不等。

多项研究显示,补这个有用,这样吃有利于糖尿病创面和溃疡愈合!

目前针对糖尿病足的营养干预研究,主要显示了补充以下维生素有利于改善创面结局。

糖尿病足创面负压创面治疗应用共识

编写组借鉴最新临床研究建议的循证实践,提出了糖尿病足 NPWT 应用和预后评估的最佳临床实践威廉亚洲博彩公司 。该共识旨在建立支持临床医生在治疗糖尿病足病例时可以参考的标准化治疗方案。

马鲁波:膝下流出道重建在糖尿病足创面干预中的重要性

糖尿病下肢严重缺血的特点以神经缺血性溃疡为主,单纯的溃疡不缺血的病人非常少,不同文献认为50%~70%的糖尿病严重缺血患者有神经缺血性糖尿病足(DMF)。

拓展阅读

Cardiovasc Diabetol:糖尿病足病史与2型糖尿病患者全因死亡率的独立关联研究

足部溃疡和/或感染是糖尿病常见的长期并发症,本研究旨在评估糖尿病足病史与2型糖尿病患者全因死亡率的关系,独立于心血管危险因素、其他并发症和合并症。

黑科技 | 肉毒毒素注射治疗糖尿病足(神经病变性足)

糖尿病足是指因糖尿病神经病变,包括未梢神经感觉障碍及植物神经损害,下肢血管病变——动脉硬化引起周围小动脉闭塞症,或皮肤微血管病变以及细菌感染所导致的足部疼病、足部溃疡及足坏疽等病变。

【探索糖尿病】研究进展、筛查评估、诊疗诊断大盘点!

深入剖析糖尿病,这些重点内容不可不看,点击立即查看。

J Diabetes:糖尿病足部溃疡患者的内侧动脉钙化是截肢和死亡的重要危险因素

在DFU患者中,足部MAC与截肢和死亡率显著相关。此外,除PAD外,足部MAC可为预测截肢提供更多的参考价值。

CGP论著 | 血清25羟维生素D3水平与糖尿病足创面愈合相关性的巢式病例对照研究

探索血清25羟维生素(OH)D3[25(OH)D3]与DF创面愈合的相关性。

一文速览威廉亚洲博彩公司 汇总——京万红软膏篇

经过几十年的临床研究,京万红软膏的主治病症种类日益扩大,被广泛用于外科、皮肤科、妇科、儿科以及五官科等,因效果显著而深受欢迎。

2024 FDA威廉亚洲博彩公司 :糖尿病足感染:开发治疗药物

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2024-06-16

糖尿病足患者复发预防的最佳证据总结

承德医学院护理学院 · 2023-06-21

糖尿病足介入综合诊治临床威廉亚洲博彩公司 (第九版)

中国糖尿病足细胞与介入治疗技术联盟 · 2024-04-25

老年糖尿病足患者创面管理的最佳证据总结

复旦大学护理学院 · 2024-04-05

FDA“糖尿病足感染:开发治疗药物的供企业用的指导原则草案”介绍

国家药品监督管理局药品审评中心(CDE) · 2024-03-08